The Latest Breaking News from Geron

Is This Penny Stock With 55% Upside A Buy Now?

This biotech company currently has an approved product on the market. However, there is more to the story than meets the eye.

Barchart · Sep 27, 2024

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ:PODD) Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes (T1D). Insulet shares traded in a range of $260.13 to $266.73 on day volume of 200.86 thousand shares…

Benzinga · Aug 22, 2022

Recap: Geron Q4 Earnings

Geron (NASDAQ:GERN) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Geron missed estimated earnings by 25.0%, reporting an EPS of $-0.1 versus an estimate of $-0.08.

Benzinga · Mar 10, 2022